111 related articles for article (PubMed ID: 6844696)
1. New applications of urinary nucleoside markers.
Borek E; Sharma OK; Waalkes TP
Recent Results Cancer Res; 1983; 84():301-16. PubMed ID: 6844696
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS.
Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E
Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341
[TBL] [Abstract][Full Text] [Related]
3. Modified nucleosides in asbestos workers at high risk of malignant disease: results of a preliminary study applying discriminant analysis.
Solomon SJ; Fischbein A; Sharma OK; Borek E
Br J Ind Med; 1985 Aug; 42(8):560-2. PubMed ID: 4016008
[TBL] [Abstract][Full Text] [Related]
4. Toward a universal tumour marker.
Borek E
Tumour Biol; 1984; 5(1):1-14. PubMed ID: 6494740
[No Abstract] [Full Text] [Related]
5. Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: application to urine samples from cancer patients.
Mrochek JE; Dinsmore SR; Waalkes TP
J Natl Cancer Inst; 1974 Dec; 53(6):1553-63. PubMed ID: 4474409
[No Abstract] [Full Text] [Related]
6. Applications of urinary nucleosides in cancer diagnosis and cancer management.
Sharma OK; Waalkes TP; Gehrke CW; Borek E
Cancer Detect Prev; 1983; 6(1-2):77-85. PubMed ID: 6309388
[No Abstract] [Full Text] [Related]
7. Transfer RNA breakdown products in the urine of asbestos workers.
Fischbein A; Sharma OK; Solomon S; Buschman F; Apell G; Kohn M; Selikoff IJ; Bekesi JG; Borek E
Cancer Detect Prev; 1984; 7(4):247-52. PubMed ID: 6488216
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of modified nucleosides in patients with malignant mesothelioma.
Fischbein A; Sharma OK; Selikoff IJ; Borek E
Cancer Res; 1983 Jun; 43(6):2971-4. PubMed ID: 6850607
[TBL] [Abstract][Full Text] [Related]
9. Modified nucleosides in body fluids of tumor-bearing patients.
Salvatore F; Colonna A; Costanzo F; Russo T; Esposito F; Cimino F
Recent Results Cancer Res; 1983; 84():360-77. PubMed ID: 6844698
[TBL] [Abstract][Full Text] [Related]
10. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
[TBL] [Abstract][Full Text] [Related]
11. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients.
Xu G; Di Stefano C; Liebich HM; Zhang Y; Lu P
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):307-13. PubMed ID: 10517352
[TBL] [Abstract][Full Text] [Related]
12. Urinary nucleosides in leukemia: laboratory and clinical applications.
Trewyn RW; Grever MR
Crit Rev Clin Lab Sci; 1986; 24(1):71-93. PubMed ID: 3539520
[TBL] [Abstract][Full Text] [Related]
13. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography.
Liebich HM; Müller-Hagedorn S; Bacher M; Scheel-Walter HG; Lu X; Frickenschmidt A; Kammerer B; Kim KR; Gérard H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):275-83. PubMed ID: 15639449
[TBL] [Abstract][Full Text] [Related]
14. Urinary nucleic acid breakdown products as markers for trophoblastic diseases.
Borek E; Sharma OK; Brewer JI
Am J Obstet Gynecol; 1983 Aug; 146(8):906-10. PubMed ID: 6309006
[TBL] [Abstract][Full Text] [Related]
15. Altered RNA turnover in carcinogenesis. The diagnostic potential of modified base excretion.
Marvel CC; Del Rowe J; Bremer EG; Moskal JR
Mol Chem Neuropathol; 1994; 21(2-3):353-68. PubMed ID: 7522008
[TBL] [Abstract][Full Text] [Related]
16. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control.
Seidel A; Brunner S; Seidel P; Fritz GI; Herbarth O
Br J Cancer; 2006 Jun; 94(11):1726-33. PubMed ID: 16685264
[TBL] [Abstract][Full Text] [Related]
17. Excretion of modified nucleosides during development of malignant lymphomas in mice after whole body irradiation.
Thomale J; Luz A; Nass G
J Cancer Res Clin Oncol; 1984; 108(3):302-7. PubMed ID: 6392304
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
Heldman DA; Grever MR; Speicher CE; Trewyn RW
J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
[TBL] [Abstract][Full Text] [Related]
19. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients.
Xu G; Liebich HM; Lehmann R; Müller-Hagedorn S
Methods Mol Biol; 2001; 162():459-74. PubMed ID: 11217356
[No Abstract] [Full Text] [Related]
20. Modified nucleosides and early detection of occupational cancer: a challenge for the future.
Fischbein A; Sharma OK; Borek E
Mt Sinai J Med; 1985 Jun; 52(6):480-3. PubMed ID: 3875030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
